Incidence and outcome of SARS-CoV-2 infection in patients with monoclonal gammopathy of undetermined significance: a case-control study

Haematologica. 2022 Feb 1;107(2):555-557. doi: 10.3324/haematol.2021.279895.
No abstract available

MeSH terms

  • COVID-19*
  • Case-Control Studies
  • Humans
  • Incidence
  • Monoclonal Gammopathy of Undetermined Significance* / diagnosis
  • Monoclonal Gammopathy of Undetermined Significance* / epidemiology
  • Paraproteinemias*
  • SARS-CoV-2